Shi Lab
Shi lab studies the role of epigenetic regulator alteration in pancreatic cancer progression and tumor microenvironment.
Research Focus
For basic and translational research, Dr. Shi’s group currently focuses on understanding how epigenetic regulations in pancreatic cancer cells impact tumor cell plasticity, tumor microenvironment, and tumor progression with a long-term goal of identifying novel therapeutic targets.
For clinical research, Dr. Shi's team is working on identifying diagnostic biomarkers for the early detection of pancreatic cancer. Dr. Shi's group is also interested in the clinicopathological and molecular characterizations of pancreatic neoplasms.
Additionally, Dr. Shi collaborates with many basic and clinical scientists on projects related to pancreatic, hepatobiliary, or GI neoplasms.
Jiaqi Shi, MD, PhD
Jiaqi Shi, MD, PhD, is a Professor of Pathology at the University of Michigan (UM). Dr. Shi received her Pathology residency training at the University of Arizona and UM and completed her subspecialty Gastrointestinal Pathology training at UM.
Our Publications
- NIH Bibliography
- KDM6A Loss Recruits Tumor-Associated Neutrophils and Promotes Neutrophil Extracellular Trap Formation in Pancreatic Cancer
- Epigenetics in precision medicine of pancreatic cancer
- KDM6A Regulates Cell Plasticity and Pancreatic Cancer Progression by Noncanonical Activin Pathway
- Neutrophil in the Pancreatic Tumor Microenvironment
- Updates in the Diagnosis of Intraductal Neoplasms of the Pancreas
- KMT2D Links TGF-β Signaling to Non-Canonical activin Pathway and Regulates Pancreatic Cancer Cell Plasticity
Lab Members
Kaiyue Ding
Hong Sun Kim, PhD
Sargis Shameon
Ranga Sudharshan
Shungang Zhang
Heizel Acosta
Wing Jiang
Erfaneh Barar, MD
Lab Fun
Lab eat out
Lab meeting
Before lab meeting
Lab gathering
Pumpkin carving competition
Lab gathering
Presenting at AACR meeting
